These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 9428572

  • 1. Muscarinic M1 and M3 receptors in rat striatum: a binding study.
    de la Vega MT, Nuñez A, Arias-Montaño JA.
    Arch Med Res; 1997; 28(4):493-7. PubMed ID: 9428572
    [Abstract] [Full Text] [Related]

  • 2. Carbachol-induced inositol phosphate formation in rat striatum is mediated by both M1 and M3 muscarinic receptors.
    de la Vega MT, Nuñez A, Arias-Montaño JA.
    Neurosci Lett; 1997 Sep 19; 233(2-3):69-72. PubMed ID: 9350834
    [Abstract] [Full Text] [Related]

  • 3. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.
    Br J Pharmacol; 1998 Nov 19; 125(5):1088-94. PubMed ID: 9846649
    [Abstract] [Full Text] [Related]

  • 4. Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M1, cardiac M2, pancreatic M3, and striatum M4 muscarinic receptors.
    Waelbroeck M, Camus J, Tastenoy M, Mutschler E, Strohmann C, Tacke R, Lambrecht G, Christophe J.
    Chirality; 1991 Nov 19; 3(2):118-23. PubMed ID: 1863523
    [Abstract] [Full Text] [Related]

  • 5. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 19; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 6. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec 19; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 7. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug 19; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 8. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec 19; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 9. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M, Gillard M, Robberecht P, Christophe J.
    Mol Pharmacol; 1987 Jul 19; 32(1):91-9. PubMed ID: 3600616
    [Abstract] [Full Text] [Related]

  • 10. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ, Oliff HS, Griffin MT.
    J Pharmacol Exp Ther; 1996 Feb 19; 276(2):405-10. PubMed ID: 8632303
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM, Lapchak PA, Quirion R.
    Synapse; 1991 Nov 19; 9(3):165-76. PubMed ID: 1776129
    [Abstract] [Full Text] [Related]

  • 12. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M, Gillard M, Robberecht P, Christophe J.
    Mol Pharmacol; 1986 Oct 19; 30(4):305-14. PubMed ID: 3762520
    [Abstract] [Full Text] [Related]

  • 13. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
    Kostka P, Ahmad S, Kwan CY, Daniel EE, Gordon RK, Chiang PK.
    J Pharmacol Exp Ther; 1992 Oct 19; 263(1):226-31. PubMed ID: 1403787
    [Abstract] [Full Text] [Related]

  • 14. Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors.
    Smith CM, Wallis RM.
    J Recept Signal Transduct Res; 1997 Oct 19; 17(1-3):177-84. PubMed ID: 9029489
    [Abstract] [Full Text] [Related]

  • 15. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
    Endou M, Hattori Y, Gando S, Kanno M.
    J Cardiovasc Pharmacol; 1992 May 19; 19(5):674-81. PubMed ID: 1381764
    [Abstract] [Full Text] [Related]

  • 16. Identification of muscarinic receptor subtypes in mouse parotid gland.
    Watson EL, Abel PW, DiJulio D, Zeng W, Makoid M, Jacobson KL, Potter LT, Dowd FJ.
    Am J Physiol; 1996 Sep 19; 271(3 Pt 1):C905-13. PubMed ID: 8843721
    [Abstract] [Full Text] [Related]

  • 17. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
    Dauphin F, Hamel E.
    J Pharmacol Exp Ther; 1992 Feb 19; 260(2):660-7. PubMed ID: 1738116
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacological analysis of drug interactions of disopyramide and its congeners with peripheral muscarinic acetylcholine receptors].
    Endou M.
    Hokkaido Igaku Zasshi; 1991 Sep 19; 66(5):677-93. PubMed ID: 1959843
    [Abstract] [Full Text] [Related]

  • 19. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I, Porta S, Schauenstein K.
    Endocrinol Exp; 1990 Mar 19; 24(1-2):125-32. PubMed ID: 2361455
    [Abstract] [Full Text] [Related]

  • 20. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S, Dolezal V, Popham A, Birdsall NJ.
    Mol Pharmacol; 2004 Jan 19; 65(1):257-66. PubMed ID: 14722259
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.